CMCSA
41
2
BF.B
59
11
CAH
53
6
V
58
6
WMB
60
8
LYB
37
12
NWL
33
8
HCP
50
2
CVS
41
2
MKC
51
3
ROP
51
3
HRL
38
3
UNP
39
4
AME
69
6
IFF
26
6
MS
48
6
PEP
50
2
ADBE
63
9
SWN
28
8
JNPR
56
2
CMCSA
41
2
BF.B
59
11
CAH
53
6
V
58
6
WMB
60
8
LYB
37
12
NWL
33
8
HCP
50
2
CVS
41
2
MKC
51
3
ROP
51
3
HRL
38
3
UNP
39
4
AME
69
6
IFF
26
6
MS
48
6
PEP
50
2
ADBE
63
9
SWN
28
8
JNPR
56
2
Financhill
Back

Harmony Biosciences Holdings 10K Form

Sell
38

HRMY
Harmony Biosciences Holdings

Last Price:
35.46
Seasonality Move:
9.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRMY News And Ratings

See the #1 stock for the next 7 days that we like better than HRMY

HRMY Financial Statistics

Sales & Book Value

Annual Sales: $437.86M
Cash Flow: $42.56M
Price / Cash Flow: 13.63
Annual Sales: $7.39
Price / Book: 4.76

Profitability

EPS (TTM): 3.10000
Net Income (TTM): $189.47M
Gross Margin: $354.37M
Return on Equity: 57.39%
Return on Assets: 31.56%

Harmony Biosciences Holdings Earnings Forecast

Key Harmony Biosciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 5 years for HRMY is 80.93%.
  • The Selling, General & Administrative Expenses for HRMY have been equal to 37.30% of Gross Profit Margin.
  • The Research & Development expenses have been 16.19% of Revenue.
  • The Interest Expense is 8.64% of Operating Income.
  • The Net Earning history of HRMY is 41.44% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

Harmony Biosciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: HRMY
Website: harmonybiosciences.com

Debt

Debt-to-Equity Ratio: 0.43
Current Ratio: 4.9
Quick Ratio: 4.64

Price-to-Earnings

Trailing P/E Ratio: 11.85
Forward P/E Ratio: 8.18

HRMY Technical Analysis vs Fundamental Analysis

Sell
38
Harmony Biosciences Holdings (HRMY) is a Sell

Is Harmony Biosciences Holdings a Buy or a Sell?